Dr. Kypreos’ team research the mechanisms underlying the development of the pathological conditions associated with metabolic syndrome with emphasis placed in the lipoprotein transport system and steroid sex hormones. Ultimate goal of their studies is the identification of novel pharmaceutical targets and the development of lead biological compounds for the treatment of these conditions.
In addition to basic research, Dr. Kypreos has extensive teaching experience. He teaches on a regular basis the courses of Pharmacology and Pharmacogenomics offered to the medical students of the University and participates in the teaching of graduate courses offered by the “Graduate Program in Basic Medical Sciences” of the Department of Medicine.
Dr. Kypreos is an EMBO Fellow, a Marie-Curie Fellow, and the winner of the 2002 “Irvine H. Page” Atherosclerosis Research Award by the ATVB council of the American Heart Association. His research activities are funded by research grants from the Hellenic GSRT, the European Research Committee (FP7) and the Industry.